Caris Precision Oncology Alliance Welcomes St. Luke’s University Health Network

St. Luke’s University Health Network joins the extensive Caris network of leading oncology institutions committed to using clinical data to advance patient care and outcomes

IRVING, TX, September 29, 2022 /PRNewswire/ — Caris Life Sciences®(Caris), the leading molecular science and technology company actively developing and delivering innovative solutions to revolutionize healthcare, today announced that St. Luke’s University Health Network (SLUHN) has joined Caris’ Precision Oncology Alliance™ (POA). The POA is a growing network of leading cancer centers around the world collaborating to advance precision oncology and biomarker-driven research. POA members work together to establish and optimize standards of care for molecular testing through innovative research focused on predictive and prognostic markers that improve clinical outcomes for cancer patients.

Founded in 1872 as the region’s first community hospital, today St. Luke’s University Health Network is a regional, not-for-profit, fully integrated, nationally recognized network of more than 17,000 employees providing services to more than one million people at 14 campuses and more than 300 outpatient sites in Pennsylvania and New Jersey. Saint-Luc is the only one Lehigh Valleybased on the healthcare system to achieve Medicare’s five-star ratings for quality, efficiency, and patient satisfaction. SLUHN is both a Leapfrog Group and Healthgrades Top Hospital and a Newsweek Best hospital in the world. US News and World Report ranked St. Luke’s #1 in the Lehigh Valley and #6 in the state.

“St. Luke’s University Health Network is thrilled to join the Caris Precision Oncology Alliance and partner with key academic and clinical institutions also dedicated to advancing precision medicine and research in biomarkers,” said Israel ZighelboimMD, FACOG, FACS, Acting Director, Department of Oncology – Cancer Center Director, St. Luke’s University Health Network.

St. Luke’s more than 1,900 physicians and providers are among the most experienced in the industry, winning awards for clinical excellence and striving daily to innovate to improve patient care. SLUHN carries on the tradition of health care in the Lehigh Valley providing primary and specialist care sites, various testing and outpatient service facilities, a regional medical school campus, the nation’s oldest operating nursing school, home care services, palliative care for inpatients and outpatients and the largest trauma network in Pennsylvania.

“The Caris Precision Oncology Alliance is thrilled to welcome St. Luke’s University Health Network as a new member as we continue to grow,” said Chadi Nabhan, MD, MBA, FACP, President of the Caris Precision Oncology Alliance. “This expanded collaborative effort of institutions across the country continues to lead to groundbreaking research to improve cancer patient outcomes.”

The Caris Precision Oncology Alliance includes 72 cancer centers and academic institutions. These institutions have early access to Caris’ extensive database and artificial intelligence platform to establish evidence-based standards for cancer profiling and molecular testing in oncology. By leveraging the comprehensive genomic, transcriptomic and proteomic profiling available through Caris Molecular Profiling, Caris seeks to provide this network with the ability to prioritize treatment options and identify clinical trial opportunities that may benefit their patients. POA members can also become part of a growing portfolio of biopharma-sponsored biomarker-directed trials. Additionally, as a member of the POA, institutions have access to Caris CODEai™, the industry’s most comprehensive data solution with cancer treatment information and clinical outcome data for more than 275,000 patients spanning over one million data points per patient.

About Caris Life Sciences

Caris life sciences® (Caris) is the leading molecular science and technology company actively developing and delivering innovative solutions to revolutionize healthcare and improve patient outcomes. Through comprehensive molecular profiling (whole exome and whole transcriptome sequencing) and the application of advanced artificial intelligence (AI) and machine learning algorithms, Caris created the Clinico-Genomics Database scale and cognitive computing needed to analyze and unravel the molecular complexity of disease. This information provides an unparalleled resource and the ideal pathway to conduct fundamental basic research to accelerate discovery for detection, diagnosis, monitoring, therapy selection and drug development to improve the human condition.

With a primary focus on cancer, Caris’ suite of state-of-the-art molecular profiling offerings assesses DNA, RNA and proteins to reveal a molecular pattern that helps patients, doctors and researchers better detect, diagnose and treat patients. Caris’ latest advancement is a blood-based circulating nucleic acid sequencing (cNAS) assay that combines comprehensive molecular analysis (whole exome and whole transcriptome sequencing from blood) and serial monitoring, which making it the most powerful liquid biopsy test ever developed.

Based at Irving, TXCaris has offices in Phoenix, New York, denver, Tokyo, Japan and Basel, Switzerland. Caris provides services across the United States, Europe, Asia and other international markets. To learn more, visit CarisLifeSciences.com or follow us on Twitter (@CarisLS).

About St. Luke’s University Health Network (SLUHN)

SLUHN is the only Lehigh Valleybased on the health care system to earn Medicare’s five stars (highest) for quality, efficiency, and patient satisfaction. It is both a Leapfrog and Healthgrades Top Hospital Group and a Newsweek Best hospital in the world. US News and World Report ranked St. Luke’s #1 in the Lehigh Valley and #6 in the state. The network’s flagship teaching hospital has won Fortune/Merative’s Top 100 Large Teaching Hospital designation a total of 10 times and eight years in a row, including 2022 when it was identified as the No. from the country. In 2021, St. Luke’s was identified as one of the top 15 healthcare systems nationwide. Utilizing the Epic electronic medical record (EMR) system for inpatient and outpatient services, the network is a multi-year recipient of the Most Wired award recognizing the breadth of SLUHN’s information technology applications such as telehealth, online scheduling and online pricing information. The network is also recognized as one of the cheapest providers in the state.

Caris Life Sciences media contact:
Lisa Burger
[email protected]
214.294.5606

St. Luke’s University Health Network Media Contact:
Sam Kennedy
[email protected]
484.526.4134

SOURCES Caris Life Sciences

About Terry Gongora

Check Also

Fighting antimicrobial resistance does not involve miracle drugs

Antibiotic sensitivity test. [iStockphoto] Africa, like other continents, has a problem with antimicrobial resistance (AMR). …